(SRNE), Amgen Inc. (NASDAQ:AMGN) - Sorrento Reports Encouraging Data From Sofusa-Administered Enbrel In Rheumatoid Arthritis
Sorrento Therapeutics Inc (NASDAQ: SRNE) reported positive initial results from the Phase 1B study of its Sofusa Lymphatic Delivery System ...
Source: benzinga.com